Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | Patent Number 10555939

US 10555939 B2
Application Number15976808
Publication NumberUS 20180325885 A1
Pendency1 year, 9 months, 7 days
Filled DateMay 10, 2018
Priority DateMay 19, 2009
Publication DateNov 15, 2018
Expiration DateMay 18, 2029
Inventor/ApplicantsMichael T. Kelly
Anthony J. Tutino
ExaminesPIPIC, ALMA
Art Unit1617
Technology Center1600
Assignments
Celgene
Current
CelgeneBristol Myers Squibb
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.